Skip To Main Content
Megan Brooks on Muck Rack

Megan Brooks

Weston
As seen in: Medscape, Business Insider, Daily Mail, HuffPost, Reuters, WebMD, Scientific American, The Globe and Mail, Flipboard, Medscape Duestch, Medscape France and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Megan

Contact Megan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

|
By Megan Brooks
| Medscape Verified
Incidental radiation exposure to the thymus during treatment for locally advanced non-small cell lung cancer (NSCLC) is associated with worse outcomes — raising questions about whether the thymus, long thought to be largely inactive in adults, should be protected during radiotherapy. In a multi-cohort study of over 1100 patients who received lung cancer radiotherapy, incidental thymic irradiation was independently associated with a higher risk for distant metastasis and, in some analyses, death.
Open in Who Shared Issue with article?

At-Home Lecanemab: What Does It Mean for Alzheimer’s Care?

|
By Megan Brooks
| Medscape Verified
With FDA approval of self-administered starting and maintenance doses of subcutaneous lecanemab (Leqembi Iqlik) in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD), antiamyloid therapy has moved beyond the infusion chair and into the home. While the change could eliminate dozens of infusion-center visits over the course of treatment, experts note that it does not turn lecanemab into a simple “take-at-home” drug.
Open in Who Shared Issue with article?

MRI Pattern May Forecast MCI to Dementia Timeline in Early-Onset Alzheimer’s Disease

|
By Megan Brooks
| Medscape Verified
A specific pattern of brain atrophy visible on MRI may help predict how quickly patients with early-onset Alzheimer’s disease (EOAD) progress from mild cognitive impairment (MCI) to dementia.
Open in Who Shared Issue with article?
See all 4,513 licensed articles (4,518 Total)